PERFORMANCE OF NON-INVASIVE TESTS (NITS) AND PREDICTORS OF OUTCOMES IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) FROM LATIN AMERICA AND NORTH AMERICA
作者
Zobair M. Younossi,Leyla de Avila,Claudia Pinto Marques Souza de Oliveira,Cristiane Alves Villela‐Nogueira,Marlén Ivón Castellanos Fernández,Adrian Carlos Gadano,Marco Antonio Arrese Jimenez,Naim Alkhouri,Winston Dunn,Giada Sebastiani,Luis Antonio Díaz Piga,Brian L. Pearlman,Juan Pablo Arab,Rida Nadeem,Felice Cinque,Nicholas Dunn,Licet González Fabián,Ahmed Almohsen,Nathalie Carvalho Leite,Ethan Friend
MASLD is highly prevalent worldwide. We evaluated performance of NITs and predictors of outcomes in patients with MASLD from Latin America (LA) as compared to North America (NA). The Global-MASLD project enrolled MASLD patients with liver biopsies and NITs (FIB-4, liver stiffness measurement (LSM) by transient elastography). NITs’ performance to predict advanced fibrosis (AF=F3-F4) and outcomes was assessed. A total of 3,904 MASLD patients were included [N=892 from 5 LA countries (Argentina, Brazil, Chile, Cuba, Mexico) and N=3012 from NA (USA/Canada). MASLD patients from LA were older, had lower BMI (obesity 64% vs. 85%), more lean MASLD (5.6% vs. 2.7%), more T2D (49% vs. 38%) (p<0.001) but similar rates of AF (p=0.56). Clinico-demographic predictors of AF included older age and T2D (p<0.05). The NIT accuracy was lower in LA-MASLD than NA-MASLD: AUC (95% CI) of FIB-4 0.75 (0.71-0.79) vs. 0.81 (0.79-0.83), LSM 0.73 (0.67-0.80) vs. 0.78 (0.75-0.81), Agile-3+ 0.76 (0.70-0.82) for both LA and NA. Sensitivity of 80% (low-risk, screening cutoff) was achieved with FIB-4 ≥1.01 in LA vs. FIB-4 ≥1.17 in NA; specificity of 95% (high-risk, diagnostic cutoff) with FIB-4 ≥2.35 vs. FIB-4 ≥2.40. In adjusted (age, sex, T2D) proportional hazards models, fibrosis severity by histology or NITs was associated with adverse outcomes (death, decompensation, HCC) in both groups (adjusted hazard ratios (aHR) >1.0) (Figure). MASLD patients from LA have more T2D but less obesity than NA. Common NITs have lower accuracy in LA-MASLD. Histologic and NIT stage of fibrosis are independent predictors of adverse outcomes in both groups.